메뉴 건너뛰기
Rheumatology International
Volumn 34, Issue 2, 2014, Pages 291-292
DPP4 inhibitor-induced polyarthritis: A report of three cases
Author keywords

DPP4 inhibitors; Drug induced polyarthritis; Type 2 diabetes mellitus
Indexed keywords

DIPEPTIDYL PEPTIDASE IV INHIBITOR; HYDROXYCHLOROQUINE; METFORMIN; METHOTREXATE; PREDNISONE; SITAGLIPTIN; VILDAGLIPTIN;
EID: 84895822043     PISSN: 01728172     EISSN: 1437160X     Source Type: Journal    
DOI: 10.1007/s00296-013-2710-7     Document Type: Article
Times cited : (41)
References (8)
  • 1
    • 33846006173 scopus 로고    scopus 로고
    • The incretin system: Glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors in type 2 diabetes
    • 1:CAS:528:DC%2BD28XhtF2gurjM 17098089 10.1016/S0140-6736(06)69705-5
    • Drucker DJ, Nauck MA (2006) The incretin system: glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors in type 2 diabetes. Lancet 368:1696-1705
    • (2006) Lancet , vol.368 , pp. 1696-1705
    • Drucker, D.J.1    Nauck, M.A.2
  • 2
    • 77952814507 scopus 로고    scopus 로고
    • Inhibition of multifunctional dipeptidyl peptidase-IV: Is there a risk of oncological and immunological adverse effects?
    • 1:CAS:528:DC%2BC3cXlt1CitLo%3D 20303610 10.1016/j.diabres.2010.02.017
    • Stulc T, Sedo A (2010) Inhibition of multifunctional dipeptidyl peptidase-IV: is there a risk of oncological and immunological adverse effects? Diabetes Res Clin Pract 88:125-131
    • (2010) Diabetes Res Clin Pract , vol.88 , pp. 125-131
    • Stulc, T.1    Sedo, A.2
  • 3
    • 0038759066 scopus 로고    scopus 로고
    • Deficiency of CD26 results in a change of cytokine and immunoglobulin secretion after stimulation by pokeweed mitogen
    • 1:CAS:528:DC%2BD3sXkvF2rtL4%3D 12778469 10.1002/eji.200323469
    • Yan S, Marguet D, Dobers J, Reutter W, Fan H (2003) Deficiency of CD26 results in a change of cytokine and immunoglobulin secretion after stimulation by pokeweed mitogen. Eur J Immunol 33:1519-1527
    • (2003) Eur J Immunol , vol.33 , pp. 1519-1527
    • Yan, S.1    Marguet, D.2    Dobers, J.3    Reutter, W.4    Fan, H.5
  • 4
    • 33845472504 scopus 로고    scopus 로고
    • Effect of the dipeptidyl peptidase-4 inhibitor sitagliptin as monotherapy on glycemic control in patients with type 2 diabetes
    • 1:CAS:528:DC%2BD2sXhtVGhtA%3D%3D 17130196 10.2337/dc06-0703
    • Aschner P, Kipnes MS, Lunceford JK, Sanchez M, Mickel C, Williams-Herman DE (2006) Effect of the dipeptidyl peptidase-4 inhibitor sitagliptin as monotherapy on glycemic control in patients with type 2 diabetes. Diabetes Care 29:2632-2637
    • (2006) Diabetes Care , vol.29 , pp. 2632-2637
    • Aschner, P.1    Kipnes, M.S.2    Lunceford, J.K.3    Sanchez, M.4    Mickel, C.5    Williams-Herman, D.E.6
  • 5
    • 33846817233 scopus 로고    scopus 로고
    • Efficacy and safety of the dipeptidyl peptidase-4 inhibitor, sitagliptin, compared with the sulfonylurea, glipizide, in patients with type 2 diabetes inadequately controlled on metformin alone: A randomized, double-blind, non-inferiority trial
    • 1:CAS:528:DC%2BD2sXjs1SrtLw%3D 17300595 10.1111/j.1463-1326.2006.00704.x
    • Nauck MA, Meininger G, Sheng D, Terranella L, Stein PP (2007) Efficacy and safety of the dipeptidyl peptidase-4 inhibitor, sitagliptin, compared with the sulfonylurea, glipizide, in patients with type 2 diabetes inadequately controlled on metformin alone: a randomized, double-blind, non-inferiority trial. Diabetes Obes Metab 9:194-205
    • (2007) Diabetes Obes Metab , vol.9 , pp. 194-205
    • Nauck, M.A.1    Meininger, G.2    Sheng, D.3    Terranella, L.4    Stein, P.P.5
  • 6
    • 33845489598 scopus 로고    scopus 로고
    • Efficacy and safety of the dipeptidyl peptidase-4 inhibitor sitagliptin as monotherapy in patients with type 2 diabetes mellitus
    • 1:CAS:528:DC%2BD28XhtFOqsrvF 17001471 10.1007/s00125-006-0416-z
    • Raz I, Hanefeld M, Xu L, Caria C, Williams-Herman D, Khatami H (2006) Efficacy and safety of the dipeptidyl peptidase-4 inhibitor sitagliptin as monotherapy in patients with type 2 diabetes mellitus. Diabetologia 49:2564-2571
    • (2006) Diabetologia , vol.49 , pp. 2564-2571
    • Raz, I.1    Hanefeld, M.2    Xu, L.3    Caria, C.4    Williams-Herman, D.5    Khatami, H.6
  • 7
    • 84859092128 scopus 로고    scopus 로고
    • RS3PE in association with dipeptidyl peptidase-4 inhibitor: Report of two cases
    • 22275459 10.2337/dc11-1995
    • Yamauchi K, Sato Y, Yamashita K, et al. (2012) RS3PE in association with dipeptidyl peptidase-4 inhibitor: report of two cases. Diabetes Care 35:e7
    • (2012) Diabetes Care , vol.35 , pp. 7
    • Yamauchi, K.1    Sato, Y.2    Yamashita, K.3
  • 8
    • 77951725805 scopus 로고    scopus 로고
    • Inhibition of fibroblast activation protein and dipeptidylpeptidase 4 increases cartilage invasion by rheumatoid arthritis synovial fibroblasts
    • 1:CAS:528:DC%2BC3cXhtFGnu7jI 20155839 10.1002/art.27395
    • Ospelt C, Mertens JC, Jungel A, et al. (2010) Inhibition of fibroblast activation protein and dipeptidylpeptidase 4 increases cartilage invasion by rheumatoid arthritis synovial fibroblasts. Arthritis Rheum 62:1224-1235
    • (2010) Arthritis Rheum , vol.62 , pp. 1224-1235
    • Ospelt, C.1    Mertens, J.C.2    Jungel, A.3

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.